EGFR tyrosine kinase inhibitors alone or in combination with chemotherapy for non-small-cell lung cancer with EGFR mutations

作者
Cuimin Zhu,Xiangyao Lian,Hongyan Zhang,Lu Bai,Wenjing Yun,Ruhan Zhao,Qingshan Li
出处
期刊:Journal of Cancer Research and Therapeutics [BioMed Central]
卷期号:17 (3): 664-670 被引量:6
标识
DOI:10.4103/jcrt.jcrt_195_20
摘要

OBJECTIVE: The objective of this study was to perform a meta-analysis comparing the efficiency of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) with chemotherapy to EGFR TKI treatment alone in patients with EGFR mutation-positive non-small cell lung cancer (NSCLC). MATERIALS AND METHODS: Following keyword queries in databases and identification of randomized control trials for inclusion, hazard ratios (HRs), relative risks (RRs), and associated 95% confidence intervals (95% CIs) were determined. RESULTS: Ten randomized controlled trials involving 1354 participants with NSCLC were evaluated. We found that a combined approach of chemotherapy with EGFR TKIs significantly improved overall survival (OS) compared with EGFR TKI alone in our patient cohort (HR = 0.47, 95% CI = 0.31-0.72). In addition, a higher overall response rate (ORR) was found for patients who received combined treatment compared to chemotherapy alone (RR = 2.17, 95% CI = 1.51-3.12). Furthermore, concomitant use of chemotherapy with TKIs significantly improved the progression-free survival (PFS) when compared to the use of TKIs alone (HR = 0.68, 95% CI = 0.49-0.95). Moreover, there was a higher ORR among patients who received combined treatment as compared to those who were managed using TKIs only (RR=1.17, 95%CI=1.09-1.25). CONCLUSION: Our meta-analysis shows that EGFR TKIs with chemotherapy confer better OS and ORR compared to either treatment alone, similarly, the combined treatment showed better PFS and ORR profiles than the use of TKI alone.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lnvvl完成签到 ,获得积分10
刚刚
张米完成签到,获得积分10
刚刚
熏风完成签到,获得积分10
刚刚
实验室发布了新的文献求助10
刚刚
江波完成签到,获得积分10
刚刚
哎哟喂完成签到,获得积分10
刚刚
爆米花的应助被111采纳,获得10
1秒前
迪迪张发布了新的文献求助10
1秒前
SciGPT的应助被潆星采纳,获得10
1秒前
www完成签到 ,获得积分10
1秒前
Akim的应助被LEETHEO采纳,获得10
2秒前
2秒前
2秒前
2秒前
zy完成签到 ,获得积分10
2秒前
orixero的应助被焦糖布丁采纳,获得10
3秒前
zyy发布了新的文献求助10
3秒前
Orange的应助被闪闪晓绿采纳,获得10
3秒前
3秒前
野性的飞机完成签到 ,获得积分10
3秒前
SYY完成签到,获得积分10
3秒前
华赛发布了新的文献求助10
3秒前
Chambray发布了新的文献求助50
3秒前
3秒前
傻傻的灵寒完成签到 ,获得积分10
4秒前
小蘑菇的应助被明朗采纳,获得10
4秒前
ykyin完成签到,获得积分20
4秒前
4秒前
Apple发布了新的文献求助10
4秒前
Tao发布了新的文献求助10
4秒前
lyang完成签到,获得积分10
5秒前
Ava的应助被阿飞采纳,获得10
5秒前
11完成签到 ,获得积分10
5秒前
6秒前
水弘发布了新的文献求助10
6秒前
慧慧完成签到,获得积分10
6秒前
6秒前
AK发布了新的文献求助10
6秒前
dhsjsj发布了新的文献求助20
6秒前
NQP完成签到,获得积分10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180617
求助须知:如何正确求助?哪些是违规求助? 9570702
关于积分的说明 21813868
捐赠科研通 7776860
什么是DOI,文献DOI怎么找? 3433294
关于科研通互助平台的介绍 2557571
邀请新用户注册赠送积分活动 2479253